---
$id: https://graph.org.ai/products/commodity/51384902
$type: Product
source: UNSPSC
code: "51384902"
title: "Rimazolium"
class: "51384900"
classTitle: "Nonsteroidal anti inflammatory pyrimidinones and pyruvates and quinazolinones and sulfones"
family: "51380000"
familyTitle: "Nonsteroidal anti inflammatory drugs NSAIDs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Rimazolium

**UNSPSC Code**: 51384902
**Class**: [Nonsteroidal anti inflammatory pyrimidinones and pyruvates and quinazolinones and sulfones](Nonsteroidal anti inflammatory pyrimidinones and pyruvates and quinazolinones and sulfones.mdx)
**Family**: [Nonsteroidal anti inflammatory drugs NSAIDs](../Nonsteroidal anti inflammatory drugs NSAIDs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C13H19N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 967Y95129A, chemically known as 3-(ethoxycarbonyl)-6,7,8,9-tetrahydro-1,6-dimethyl-4-oxo-4h-pyrido(1,2-a)pyrimidinium but generally known as rimazolium, which bears US NIH Compound Identifier 71940. European Medicines Agency schedules Rimazolium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15142MIG. World Health Organization schedules rimazolium in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, RIMAZOLIUM remains the US FDA Preferred Term for this commodity. Rimazolium bears US NLM identifiers UMLS ID C0072022 and NCI Concept Code C84138. SMILES: O=C1N2C(CCCC2[N](CC1C(=O)OCC)C)C.

